Travere Therapeutics, Inc. - Common Stock (TVTX) stock analysis

TVTX · Travere Therapeutics, Inc. - Common Stock

Latest recorded price: USD 49.70

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 32.3%, ROIC -40.3%.

Similar companies in Healthcare